Revenue, 2025

USD 2.45 Billion

Forecast, 2035

USD 5.64 Billion

CAGR, 2026-2035

8.7%

Report Coverage

Global

Intracranial Aneurysm Market Trends for 2026

The global intracranial aneurysm market size was estimated at USD 2.45 billion in 2025 and is predicted to increase from USD 2.66 billion in 2026 to approximately USD 5.64 billion by 2035, expanding at a CAGR of 8.7% from 2026 to 2035. The market is witnessing strong momentum, fueled by rising awareness of neurological disorders and increasing preference for advanced minimally invasive treatment options. Continuous innovation in neurovascular devices and improved diagnostic capabilities are further accelerating market growth and shaping future opportunities.

Key Takeaways

• Intracranial aneurysm market to crossed USD 2.66 billion by 2026.
• Market projected at USD 5.64 billion by 2035.
• CAGR of 8.7% expected in between 2026 to 2035.
• North America dominated the intracranial aneurysm market with a share of 38% in 2025.
• Asia Pacific held 24% share of the market in 2025 and is expected to grow at the fastest CAGR of 10.1% in the market during the forecast period.
• By type, the saccular aneurysm segment dominated the market with a revenue share of 68% in 2025.
• By type, the fusiform aneurysm segment held the second-largest share of 14% of the market in 2025 and is expected to grow at the fastest CAGR of 9.2% in the market during the forecast period.
• By treatment type, the endovascular coiling segment led the market with a share of 38% in 2025.
• By treatment type, the flow diversion devices segment held 18% share in 2025 and is expected to grow at the fastest CAGR of 11.2% in the market during the forecast period.
• By end user, the hospitals segment held a dominant share of 72% in 2025.
• By end user, the specialty clinics segment held the second-largest share of 18% of the market in 2025 and is expected to grow at the fastest CAGR of 9.1% in the market during the forecast period.
• By diagnosis modality, the digital subtraction angiography (DSA) segment led the market with a share of 36% in 2025.
• By diagnosis modality, the magnetic resonance imaging (MRI) segment held 30% share in 2025 and is expected to grow at the fastest CAGR of 9% in the market during the forecast period.

Rising Neurological Cases Boost Market Expansion

An intracranial aneurysm is a weak, bulging area in a blood vessel wall within the brain that balloons outward due to pressure from blood flow. If it ruptures, it can cause serious bleeding in the brain and become life-threatening. The intracranial aneurysm market is experiencing steady growth due to the increasing incidence of brain vascular disorders, hypertension, and an aging population. Growing demand for early diagnosis, improved neuroimaging systems, and minimally invasive treatment options such as coiling and flow diversion is further boosting market expansion. Continuous technological advancements in neurovascular devices are also creating strong opportunities for future growth.

How Can AI Affect the Intracranial Aneurysm Market?

AI is positively impacting the market by improving the speed and accuracy of diagnosis, helping assess rupture risk, and supporting personalized treatment decisions. Its integration with advanced imaging and surgical planning tools enhances procedural precision, improves patient outcomes, and increases demand for innovative neurovascular devices and smart healthcare solutions.

Trend and Future Outlook of the Intracranial Aneurysm Market?

• Growing Preference for Minimally Invasive Care: Healthcare providers are increasingly adopting less invasive treatment approaches due to shorter hospital stays, reduced complications, and faster recovery. This shift is expected to continue driving demand for advanced neurovascular devices and innovative procedural techniques.
• Expansion of AI and Smart Imaging Solutions: The use of AI in diagnostic imaging and treatment planning is becoming a major market trend. It supports earlier detection, better risk evaluation, and more precise interventions, creating strong opportunities for technology-driven market growth.
• Rising Demand Across Emerging Regions: Improving healthcare infrastructure, greater awareness of neurological conditions, and increased access to specialized treatment centers are supporting market expansion in developing regions. These areas are expected to offer significant future growth opportunities for manufacturers and healthcare providers.

 Executive Summary Table

Segmental Insights

By Type Insights

The Saccular Aneurysm Segment Dominated the Market in 2025

The saccular aneurysm segment dominated the intracranial aneurysm market with a share of 68% in 2025 because it is the most frequently diagnosed type of intracranial aneurysm, making it the primary focus of diagnosis and treatment. Its dominance is further supported by strong adoption of minimally invasive procedures, better clinical detection rates, and continuous advancements in neurovascular devices, which together contributed to the market growth.

The fusiform aneurysm segment held the second-largest share of 14% of the market in 2025 and is expected to grow at the fastest CAGR of 9.2% in the market during the forecast period due to the increasing incidence of complex vascular abnormalities and growing diagnosis rates through advanced imaging technologies. Rising adoption of specialized endovascular treatment and improved clinical management for difficult aneurysms further supported segment growth, contributing significantly to its strong market presence and revenue share.

The dissecting aneurysm segment held 10% of the intracranial aneurysm market share in 2025 due to rising awareness of rare cerebrovascular conditions and improved detection through high-resolution imaging technologies. Increasing cases linked to trauma, hypertension, and vascular disorders are also contributing to demand. In addition, advancements in specialized endovascular treatment options and growing access to neurovascular care are supporting the segment’s continued expansion across healthcare markets.

The mycotic aneurysm segment held 8% of the intracranial aneurysm market share in 2025 due to the increasing incidence of bloodstream infections, infective endocarditis, and weakened immune conditions that raise the risk of infected cerebral aneurysms. Improved diagnostic imaging and earlier clinical recognition are supporting faster diagnosis and treatment. Additionally, growing use of targeted antimicrobial therapies and advanced neurovascular interventions is further driving segment growth.

By Treatment Type Insights

The Endovascular Coiling Segment Led the Market in 2025 with the Largest Share

The endovascular coiling segment led the intracranial aneurysm market with a 38% share in 2025 due to its strong preference as a minimally invasive treatment option for intracranial aneurysms. It offers shorter recovery time, reduced surgical risk, and lower hospital stay compared with open surgery. Its wide clinical acceptance, high success rate, and continuous advances in coil technology have further strengthened its dominant market position.

The surgical clipping segment second-largest share of 22% of the market in 2025 due to its continued use in treating complex and large aneurysms that may not be suitable for minimally invasive procedures. It remains a trusted option for long-term aneurysm closure, especially in critical cases requiring direct surgical access. Strong clinical confidence, established surgical expertise, and consistent demand in tertiary care centers continue to support its market position.

The flow diversion devices segment held 18% share in 2025 and is expected to grow at the fastest CAGR of 11.2% in the market during the forecast period due to rising adoption for treating complex, wide-neck, and large intracranial aneurysms. These devices offer improved long-term vessel reconstruction, lower recurrence rates, and better outcomes in difficult cases. Continuous technological advancements and increasing physician preference for minimally invasive neurovascular solutions are further accelerating segment growth.

The stent-assisted coiling segment held 14% of the intracranial aneurysm market share in 2025 due to its increasing use in treating wide-neck and complex intracranial aneurysms that are difficult to manage with conventional coiling alone. The technique provides better coil stability, improves aneurysm occlusion, and reduces recurrence risk. Rising adoption of advanced stent technologies and growing preference for minimally invasive neurovascular procedures are further supporting segment growth.

By End User Insights

The Hospitals Segment held a Dominant Position in the Market in 2025

The hospitals segment held a dominant share of 72% in 2025 due to the high volume of intracranial aneurysm diagnoses, emergency admissions, and advanced treatment procedures performed in hospital settings. Hospitals are equipped with specialized neuroimaging systems, neurosurgical teams, and intensive care facilities, making them the primary choice for both diagnosis and complex interventions, thereby driving their leading market share.

The specialty clinics segment held the second-largest share of 18% of the intracranial aneurysm market in 2025 and is expected to grow at the fastest CAGR of 9.1% in the market during the forecast period due to the growing demand for focused neurovascular care, faster diagnosis, and specialized treatment services. These clinics offer consultations, advanced imaging support, and minimally invasive treatment options in a more streamlined setting. Increasing patient preference for specialized care and shorter waiting times further contributed to the segment’s strong market presence.

The ambulatory surgical centers (ASCs) segment held 10% market share in 2025 and is growing steadily due to increasing preference in outpatient settings. ASCs offer shorter procedure times, reduced hospital stays, and faster patient recovery, making them an attractive option for selected aneurysm treatments. Rising healthcare cost pressure and expanding availability of advanced neurovascular technologies are further supporting segment growth.

By Diagnosis Modality Insights

The Digital Subtraction Angiography (DSA) Segment Dominated the Market in 2025

The digital subtraction angiography (DSA) segment led the intracranial aneurysm market with a share of 36% in 2025 due to its high accuracy in detecting intracranial aneurysms and detailed visualization of cerebral blood vessels. It remains the gold-standard diagnostic technique for precise aneurysm localization, size assessment, and treatment planning. Its widespread use in hospitals and neurovascular centers for both diagnosis and interventional guidance further strengthened its market leadership.

The computed tomography (CT) segment held the second-largest share of 34% of the market in 2025 due to its rapid imaging capability, wide availability, and strong use in emergency settings for suspected aneurysm rupture cases. CT scans enable the quick detection of brain bleeding and support timely clinical decisions. Growing adoption of advanced CT angiography systems and improved imaging resolution further contributed to the segment’s substantial market share.

The magnetic resonance imaging (MRI) segment held 30%  share in 2025 and is expected to grow at the fastest CAGR of 9.0% in the intracranial aneurysm market during the forecast period due to its superior soft-tissue visualization, non-invasive nature, and absence of radiation exposure. Increasing use for early aneurysm detection, follow-up monitoring, and detailed vascular assessment is driving demand. Advancements in high-resolution MR angiography technologies are further accelerating segment growth across diagnostic centers and hospitals.

Regional Insights

North America Strong Healthcare Infrastructure Fuels Growth

North America dominated the intracranial aneurysm market with a share of 38% in 2025 due to its advanced healthcare infrastructure, high awareness of neurological disorders, and strong adoption of minimally invasive neurovascular procedures. The region also benefits from the advances of major medical device companies, widespread access to advanced imaging technologies, and the increasing incidence of hypertension and age-related cerebrovascular conditions, which continue to drive market growth.

U.S. Market Trends

The U.S. intracranial aneurysm market is leading due to its advanced healthcare infrastructure, high adoption of innovative neurovascular devices, and strong presence of major medical technology companies. The rising prevalence of hypertension, stroke risk, and age-related cerebrovascular disorders further supports demand. In addition, widespread access to advanced imaging systems and specialized neurosurgical centers continues to strengthen the country’s dominant market position.

Asia Pacific Drives Breakthrough Innovations

Asia Pacific captured 24% of the total market share in 2025 and is anticipated to grow at the fastest CAGR of 10.1% in the intracranial aneurysm market during the forecast period due to improving healthcare infrastructure, rising awareness of neurological disorders, and increasing access to advanced diagnostic and treatment technologies. Growing elderly population, higher incidence of hypertension and stroke-related conditions, along with expanding investments in healthcare facilities, are further accelerating market growth across the region.

India Market Trends

India is anticipated to grow at the fastest CAGR in the intracranial aneurysm market during the forecast period due to improving healthcare infrastructure, rising awareness of neurological disorders, and increasing access to advanced diagnostic imaging and minimally invasive treatments. A large patient population, growing incidence of hypertension and stroke-related conditions, along with higher investments in specialty hospitals and neurovascular care, are further accelerating market expansion.

Supply Chain Analysis

Clinical Trials

• Clinical trials in the intracranial aneurysm market mainly focus on assessing the safety and performance of advanced endovascular devices, especially flow diverters and coiling systems. Research is also aimed at improving treatment outcomes for both ruptured and unruptured aneurysms, along with better blood pressure control strategies to reduce complications and recurrence risk.
• Key players: Stryker, Medtronic, Terumo, Penumbra, Johnson & Johnson, MicroPort Scientific.

R&D

• Research and development in the intracranial aneurysm is advancing quickly, with a strong focus on minimally invasive endovascular solutions, AI-enabled diagnostic technologies, and personalized treatment approaches. Companies are investing in smarter imaging systems, next-generation flow diversion devices, and targeted therapies to improve patient outcomes.
• Key players: Stryker, Medtronic, Terumo, Penumbra, MicroPort Scientific, Balt, Acandis.

Patient Support and Services

• Patient support and services cover the entire care journey, from early diagnosis and specialized treatment to post-procedure monitoring and long-term rehabilitation. The focus is on improving recovery, managing neurological and cognitive complications, and enhancing quality of life.
• Key players: Stryker, Medtronic, Johnson & Johnson, Terumo, Penumbra, MicroPort Scientific.

Top Vendors in the Intracranial Aneurysm Market & Their Offerings

SWOT Analysis

Strengths

• Strong demand driven by the rising prevalence of hypertension, stroke, and an aging population
• Growing adoption of minimally invasive procedures such as coiling and flow diversion
• Continuous technological advancements in neurovascular devices and imaging systems
• Presence of established global medical device companies and specialty care centers

Weaknesses

• High treatment and device costs limit access in price-sensitive markets
• Risk of procedural complications and recurrence in certain aneurysm cases

Opportunities

• Expanding use of AI in early diagnosis and treatment planning
• Rapid growth potential in emerging markets such as India and the Asia Pacific
• Increasing investment in R&D for next-generation flow diverters and smart devices
• Rising demand for outpatient and minimally invasive neurovascular procedures

Threats

• Strict regulatory approvals and long product development timelines
• Intense competition among major device manufacturers

What are the Recent Developments in the Intracranial Aneurysm Market?

• In January 2026, Boston Scientific signed a definitive agreement to acquire Penumbra, Inc., aiming to strengthen its footprint in cardiovascular and neurovascular care. The acquisition is expected to expand its offerings in high-growth vascular treatment areas, particularly mechanical thrombectomy and advanced neurovascular intervention technologies, further reinforcing its position in the intracranial aneurysm and stroke care market.
• In July 2025, RSNA introduced the Intracranial Aneurysm Detection AI Challenge to speed up innovation in AI-based radiology tools and improve patient outcomes. Conducted in collaboration with leading neuroradiology and neurointerventional societies, the initiative focuses on enhancing AI-driven detection and precise localization of intracranial aneurysms using imaging techniques such as CTA, MRA, and MRI.

Segments Covered in the Report

By Type

• Saccular Aneurysm
  • Berry Aneurysm
• Fusiform Aneurysm
• Dissecting Aneurysm
• Mycotic Aneurysm

By Treatment Type

• Surgical Coiling
  • Bare Meal Coils
  • Hydrogel Coils
• Flow Diersion Devices
• Stent-Assisted Coiling
• Liquid Embolic Agents

By End User

• Hospitals
  • Public Hospitals
  • Private Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

By Diagnosis Modality

• Computed Tomography (CT)
  • CT Angiography (CTA)
• Magnetic Resonance Imaging (MRI)
  • MR Angiography (MRA)
• Digital Subtraction Angiography (DSA)

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA